调脾护心法治疗冠心病介入术后296例患者回顾性队列研究  

Retrospective cohort study on justing-spleen-treating-heart for PCI treatment of coronary heart disease

作　　者：吴焕林[1] 罗文杰[1] 林思松[2] 

机构地区：[1]广东省中医院心脏中心,广东广州510105 [2]广州中医药大学,广东广州510515

出　　处：《中国现代医学杂志》2009年第8期1220-1222,共3页China Journal of Modern Medicine

基　　金："十一.五"国家科技支撑计划课题"名老中医临床经验(病证结合)应用研究"(No:2007BAI10B02)资助

摘　　要：目的评价调脾护心法治疗对冠心病介入术后患者预后影响。方法电话随访自2003年来在广东省中医院确诊为急性心肌梗塞(AMI),并接受经皮冠状动脉腔内血管成形术(PTCA)和(或)支架置人术的患者共296例,按照是否接受调脾护心法治疗分为两个队列(对照组和治疗组),接受调脾护心法中医药治疗+常规西医治疗者48例,男27例,女21例。无接受调脾护心法中医药治疗,只接受常规西医治疗或(且)非调脾护心法中医药治疗者248例,男158例,女90例。结果应用调脾护心治法给予中药治疗的术后患者中,再发胸闷胸痛占12.5%,再次手术0%,出现胃出血胃部不适等消化道症状占2.0%。未应用调脾护心法给予中药治疗的术后患者中,再发胸闷胸痛17.3%,再次手术0.8%,出现胃出血胃部不适等消化道症状占3.2%。结论运用调脾护心法治疗,可以减少冠心病支架术后患者心血管事件的发生,同时能减少因长期服用阿司匹林等西药引起的胃肠道并发症,改善冠心病支架术后患者生活质量。[Objective] To evaluate the cured influence that the therapy of justing-spleen-treating-heart. On the patients with coronary disease. [Methods] To follow up 352 patients by telephone, who have been diagnosed as AMT and accepted PTCA in Chinese medicine hospital of Guangdong Province, excluding 56 cases of dying when being hospitalized, the rest will be classified into two groups （the contrapositive group and therapeutical group）. There are 48 patients who have accepted the Chinese medicine treatment and conventional western treatment in the first group, including 27 men and 21 women. There are 248 patients who only have accepted conventional western treatment without the Chinese medicine treatment or other Chinese medicine treatment, including 158 men and 90 women. [Results] After accepting the treatment, the patients whose chests distressed and pained occupied 12.5%, the ones who have to operate again occupied 0% and the ones who have the gastrointestinal symptoms such as gastrorrhagia, gastric distress and so on. occupied 2.0%. And in the patients who accepts other Chinese medicine treatments, the ones whose chests distressed and pained again oceupied 71.3%. 0.8% have to accept a second operation and 3.2% have the gastrointestinal symptoms such as gastrorrhagia, gastric distress and so on. [Conclusion] The use of justing-spleen-treating-heart, can reduce coronary heart disease in patients with cardiovascular stent after the incident occurred at the same time to reduce the long-term use of aspirin and other medicine Baidoa from the gastrointestinal tract complications, improve coronary heart disease stenting after the quality of life.

关 键 词：调脾护心法 冠心病 

分 类 号：R541.4[医药卫生—心血管疾病]